Home NDC 50090-4396 naproxen
Product NDC 50090-4396
11-digit product format 500904396
Labeler code 50090
Product ID 50090-4396_0a75f95f-c138-46cb-8c6e-c76b4d561f9a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name naproxen
Dosage form TABLET
Route ORAL
Labeler A-S Medication Solutions
Application ANDA091305
Marketing category ANDA
Marketing start 2016-07-05
Marketing end 0000-00-00
Substance NAPROXEN
Active strength 500 mg/1
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 45 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091305-001 NAPROXEN NAPROXEN 250MG TABLET / ORAL 2011-08-24 A091305-002 NAPROXEN NAPROXEN 375MG TABLET / ORAL 2011-08-24 A091305-003 NAPROXEN NAPROXEN 500MG TABLET / ORAL 2011-08-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 126 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091305-002 NAPROXEN 375MG TABLET / ORAL 2011-08-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091305-003 NAPROXEN 500MG TABLET / ORAL 2011-08-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091305-001 NAPROXEN 250MG TABLET / ORAL 2011-08-24 1e350fbaab3a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 78 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-4396-0 naproxen 30 in 1 BOTTLE TABLET 30 1 50090-4396-1 naproxen 30 in 1 BOTTLE TABLET 30 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-4396 NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] 1 Legacy NDC, 2 package rows 20200711_25166477-afd9-4ce3-a33d-05f313ca0728.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join naproxen NAPROXEN Cipla USA Inc. a9549a47-3fa4-4a2b-95ac-b00e43aedae7 2023-01-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091305 application number: ANDA091305 Naproxen NAPROXEN Exelan Pharmaceuticals, Inc. 46dbdb95-a0d0-4410-8d64-b22763b12af7 2020-08-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091305 application number: ANDA091305 Naproxen NAPROXEN Aphena Pharma Solutions - Tennessee, LLC e2347581-90da-429a-b17c-cffd0039fb86 2017-10-23 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091305 application number: ANDA091305
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-4396-0 50090439600 30 TABLET in 1 BOTTLE (50090-4396-0) 30 tablet 2019-06-28 0000-00-00 No No Current 50090-4396-1 50090439601 30 TABLET in 1 BOTTLE (50090-4396-1) 30 tablet 2019-06-28 0000-00-00 No No Current